爱尔眼科(300015) - 2018 Q1 - 季度业绩预告

Financial Performance - The company expects a net profit of approximately RMB 202.32 million to RMB 217.88 million for Q1 2018, representing a year-on-year increase of 30% to 40%[3] - The net profit for the same period last year was RMB 155.63 million[3] - The increase in net profit is attributed to a rapid increase in outpatient and surgical volumes, as well as successful implementation of internationalization strategies[5] - Non-recurring gains and losses are expected to impact net profit by approximately RMB 4 million[6] Market Position and Strategy - The company's brand influence has strengthened, leading to an increase in market share and improved operational efficiency[5] - The company emphasizes the importance of rational investment and risk awareness for investors[6] Financial Reporting - The financial data in the earnings forecast has not been audited by a registered accountant[4] - The earnings forecast period is from January 1, 2018, to March 31, 2018[3] - The company will provide detailed financial data in the Q1 2018 report[6] - The earnings forecast is based on preliminary calculations by the company's finance department[6]